NZ189626A - Halogen substituted mercaptoacylimino acids pharmaceutical compositions - Google Patents

Halogen substituted mercaptoacylimino acids pharmaceutical compositions

Info

Publication number
NZ189626A
NZ189626A NZ189626A NZ18962679A NZ189626A NZ 189626 A NZ189626 A NZ 189626A NZ 189626 A NZ189626 A NZ 189626A NZ 18962679 A NZ18962679 A NZ 18962679A NZ 189626 A NZ189626 A NZ 189626A
Authority
NZ
New Zealand
Prior art keywords
mercaptoacylimino
pharmaceutical compositions
halogen substituted
acids
acids pharmaceutical
Prior art date
Application number
NZ189626A
Inventor
M Ondetti
P Sprague
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/939,147 external-priority patent/US4154935A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NZ189626A publication Critical patent/NZ189626A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NZ189626A 1978-02-21 1979-02-12 Halogen substituted mercaptoacylimino acids pharmaceutical compositions NZ189626A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87903278A 1978-02-21 1978-02-21
US93914878A 1978-09-01 1978-09-01
US05/939,147 US4154935A (en) 1978-02-21 1978-09-01 Halogen substituted mercaptoacylamino acids

Publications (1)

Publication Number Publication Date
NZ189626A true NZ189626A (en) 1982-03-09

Family

ID=27420501

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ189626A NZ189626A (en) 1978-02-21 1979-02-12 Halogen substituted mercaptoacylimino acids pharmaceutical compositions

Country Status (26)

Country Link
JP (1) JPS54125656A (en)
AR (2) AR229152A1 (en)
CA (1) CA1124723A (en)
CH (1) CH639370A5 (en)
CS (1) CS230562B2 (en)
DD (1) DD141827A5 (en)
DE (1) DE2906768A1 (en)
DK (1) DK73379A (en)
ES (3) ES477878A1 (en)
FI (1) FI790593A (en)
FR (1) FR2417499A1 (en)
GB (1) GB2014987B (en)
GR (1) GR82336B (en)
HK (1) HK41383A (en)
IE (1) IE47971B1 (en)
IL (1) IL56662A0 (en)
LU (1) LU80946A1 (en)
NL (1) NL7901319A (en)
NO (1) NO790568L (en)
NZ (1) NZ189626A (en)
PH (1) PH15381A (en)
PL (1) PL118158B1 (en)
PT (1) PT69254A (en)
RO (1) RO77228A (en)
SE (1) SE431643B (en)
SU (1) SU882409A3 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NL7809120A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES.
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
CA1132985A (en) * 1978-12-22 1982-10-05 John Krapcho Ketal and thioketal derivatives of mercaptoacyl prolines
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
US4288368A (en) * 1979-07-30 1981-09-08 E. R. Squibb & Sons, Inc. Dithioacylproline derivatives
AU542211B2 (en) * 1980-03-07 1985-02-14 Gruppo Lepetit S.P.A. Mercaptocycloalkyl carbonyl prolines
JP2005213165A (en) * 2004-01-28 2005-08-11 Mitsui Chemicals Inc Method for producing fluoroproline compounds
JP2011121872A (en) * 2009-12-08 2011-06-23 Central Glass Co Ltd Method for purifying optically active n-tert-butoxycarbonyl-trans-4-fluoroproline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
HK41383A (en) 1983-10-21
FR2417499B1 (en) 1982-06-04
ES477878A1 (en) 1980-03-01
NO790568L (en) 1979-08-22
IE47971B1 (en) 1984-08-08
GB2014987A (en) 1979-09-05
AR229152A1 (en) 1983-06-30
JPH0134986B2 (en) 1989-07-21
LU80946A1 (en) 1979-06-18
RO77228A (en) 1981-08-17
GB2014987B (en) 1982-11-03
CS230562B2 (en) 1984-08-13
IE790297L (en) 1979-08-21
ES479832A1 (en) 1979-11-16
ES479833A1 (en) 1979-11-16
JPS54125656A (en) 1979-09-29
CH639370A5 (en) 1983-11-15
SE431643B (en) 1984-02-20
SU882409A3 (en) 1981-11-15
PT69254A (en) 1979-03-01
PH15381A (en) 1982-12-17
SE7901510L (en) 1979-08-22
PL118158B1 (en) 1981-09-30
NL7901319A (en) 1979-08-23
PL213593A1 (en) 1980-02-25
DK73379A (en) 1979-08-22
FR2417499A1 (en) 1979-09-14
DE2906768A1 (en) 1979-08-23
FI790593A (en) 1979-08-22
IL56662A0 (en) 1979-05-31
AR228036A1 (en) 1983-01-14
GR82336B (en) 1984-12-13
CA1124723A (en) 1982-06-01
DD141827A5 (en) 1980-05-21

Similar Documents

Publication Publication Date Title
ZA79612B (en) Halogen substituted mercaptoacylamino acids
GB2039738B (en) Inflammation - preventing pharmaceutical composition
NZ189574A (en) Dehydrocyclicimino acid derivatives pharmaceutical compositions
JPS54132223A (en) Novel pharmaceutical composition
ZA787000B (en) Pharmaceutical formulation
IL58656A0 (en) Halogen substituted benzopyran-and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
NZ189626A (en) Halogen substituted mercaptoacylimino acids pharmaceutical compositions
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
GB2011785B (en) Coated pharmaceutical compositions
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
NZ191140A (en) 1-phenylpiperazine derivatives pharmaceutical compositions
GB2034587B (en) Pharmaceutical compositions
IL58061A0 (en) The preparation of arylglyoxylic acids
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
NZ191048A (en) 1-benzoyl-3-pyridinyl-urea derivatives isecticidal compositions
IL57451A0 (en) The preparation of arylglyoxylic acids
JPS54154516A (en) Pharmaceutical composition
ZA794484B (en) Pharmaceutical compositions
AU4542979A (en) Pharmaceutical compositions
ZA791032B (en) Pharmaceutical compositions
NZ190958A (en) 2-phenylamino-2-imidazoline derivatives pharmaceutical compositions